Status:
COMPLETED
The Effect of Fibrate Therapy in Two Patients With Neutral Lipid Storage Disease With Myopathy (NLSDM)
Lead Sponsor:
Maastricht University Medical Center
Conditions:
Neutral Lipid Storage Disease
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
Neutral Lipid Storage Disease With Myopath (NLSDM) is a disease caused by a defect in the PNPLA2 gene encoding ATGL. Patients with NLSDM accumulate triglycerides and exhibit muscle weakness, cardiac f...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- suffering from NLSDM
Exclusion
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT01527318
Start Date
August 1 2011
End Date
December 1 2012
Last Update
May 14 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht University Medical Center
Maastricht, Limburg, Netherlands, 6200MD